Vascular risk factors in patients with type 1 diabetes

Practical Diabetes International

Volumn 22, Issue 3, 2005, Pages 81-85

  Wallymahmed, Maureen E ^a   Pinkney, J ^a   Saunders, S ^a   MacFarlane, I A ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Dyslipidaemia; Glycated haemoglobin; Hypertension; Microalbuminuria; Type 1 diabetes; Vascular risk factors

Indexed keywords

ALBUMIN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DIABETES CONTROL; DIABETIC ANGIOPATHY; DIABETIC HYPERTENSION; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLYCEMIC LOAD; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFE EXPECTANCY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

EID: 23044483298     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.761     Document Type: Article

References (23)

1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
2. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, I: all cause mortality in patients with insulin treated diabetes mellitus. Diabetic Med 1999; 16: 459-465.
3. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabetic Med 1999; 16: 466-471.
4. Dorman TJ, Laporte RE, Kuller LH, et al. The Pittsburgh insulin dependent diabetes mellitus (IDDM) morbidity and mortality study. Diabetes 1984; 133: 271-276.
5. Borch-Johnsen K, Nissen H, Henriksen E, et al. The natural history of insulin dependent diabetes in Denmark: 1. Long term survival with and without late complications. Diabetic Med 1986; 4: 201-210.
6. Laing SP, Swerdlow AJ, Carpenter LM, et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin treated diabetes. Stroke 2003; 34: 418-421.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
8. Orchard TJ, Dorman JS, Maser RE, et al. Factors associated with avoidance of severe complications after 25yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 1990; 13: 741-747.
9. European Diabetes Policy Group. A desktop guide to type 1 (insulin dependent) diabetes mellitus. Diabetic Med 1999; 16: 253-256.
10. Saunders S, Wallymahmed ME, MacFarlane IA. The glycaemic control achieved in a younger adult type 1 diabetes clinic. Quarterly J Med 2004; 97: 575-580.
11. National Institute for Clinical Excellence. Type 1 diabetes: management of Type 1 diabetes in adults in primary and secondary care (Draft Version 1.6). National Institute for Clinical Excellence, 2004.
12. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta analysis of randomised controlled trials. BMJ 2002; 324: 705-708.
13. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325: 746-749.
14. Perez A, Wagner AM, Carreras G, et al. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus. Archives Intern Med 2000; 160: 2756-2762.
15. Perez A, Caixas A, Carreras G, et al. Lipoprotein compositional abnormalities in type 1 diabetes: Effect of improved glycaemic control. Diabetes Res Clin Pract 1997; 36: 83-90.
16. Tabaei BP, Al Kassab AS, Ilag LL, et al. Does microalbiminuria predict diabetic nephropathy? Diabetes Care 2001; 24: 1560-1566.
17. Almdal T, Norgaard K, Feldt-Rasmussen B, et al. The predictive value of microalbuminuria in IDDM. A five year follow up study. Diabetes Care 1994; 17: 120-125.
18. The EUCLID Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-1792.
19. Lovell HG. Angiotensin converting enzymes in normotensive diabetic patients with microalbuminuria (Cochrane Review). In The Cochrane Library, Issue 2. Chichester: John Wiley & Sons, 2004.
20. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
21. United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998: 317: 703-713.
22. New JP, Mason JM, Freemantle N, et al. Specialist nurse-led intervention to treat and control hypertension and hyperlipidaemia in diabetes (SPLINT): a randomised controlled trial. Diabetes Care 2003; 26: 2250-2255.
23. Denver EA, Woolfson RG, Barnard M, et al. Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type 2 diabetes. Diabetes Care 2003; 26: 2256-2260.